Advances in stroke: Imaging 2013

Affiliations

¹ From the Max Planck Institute for Neurological Research, Cologne, Germany (W.-D.H.); and Departments of Neurology and Medical Imaging, University of Arizona, Tucson, AZ (C.S.K.).

Wolf-Dieter Heiss et al. Stroke. 2014 Feb.

. 2014 Feb;45(2):363-4.

doi: 10.1161/STROKEAHA.113.004102. Epub 2014 Jan 16.

¹ From the Max Planck Institute for Neurological Research, Cologne, Germany (W.-D.H.); and Departments of Neurology and Medical Imaging, University of Arizona, Tucson, AZ (C.S.K.).

No abstract available

Keywords: diagnostic imaging; hemorrhage; magnetic resonance imaging; penumbra; recovery; stroke.

References

1. Ogata T, Christensen S, Nagakane Y, Ma H, Campbell BC, Churilov L, et al. The effects of alteplase 3 to 6 hours after stroke in the epithet-defuse combined dataset: Post hoc case-control study. Stroke. 2013;44:87–93. - PubMed
1. Inoue M, Mlynash M, Straka M, Kemp S, Jovin TG, Tipirneni A, et al. Clinical outcomes strongly associated with the degree of reperfusion achieved in target mismatch patients: Pooled data from the diffusion and perfusion imaging evaluation for understanding stroke evolution studies. Stroke. 2013;44:1885–1890. - PMC - PubMed
1. Warach S, Al-Rawi Y, Furlan AJ, Fiebach JB, Wintermark M, Lindsten A, et al. Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: Insights from the desmoteplase in acute stroke trials. Stroke. 2012;43:2313–2318. - PubMed
1. Fiebach JB, Al-Rawi Y, Wintermark M, Furlan AJ, Rowley HA, Lindsten A, et al. Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase. Stroke. 2012;43:1561–1566. - PubMed
1. Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012;366:1099–1107. - PubMed